Human Health
Found the followig item down in the notes which seems to indicate additional work going on in the background of the cannabis product development:
"Avecho’s Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches.
The division continues to prioritise development work on the two existing opioid patch assets: TPM®/Oxymorphone and
TPM®/Oxycodone as well as continue to assess commercial opportunities for TPM® enhanced products delivered as
injectables"
Kens
Ann: Appendix 4D and Half-year Financial Report, page-3
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $2.23K | 751.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 102805577 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 23045578 | 12 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |